A Clinical Trial Evaluating Patients With Primary Vitreoretinal Lymphoma — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

A Clinical Trial Evaluating Patients With Primary Vitreoretinal Lymphoma — Stella

Home/Primary Vitreoretinal Lymphoma/

View on ClinicalTrials.gov

Recruiting

Back to Primary Vitreoretinal Lymphoma trials

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(1 site)

United States

Bascom Palmer Eye Institute, Miami, Florida

Key details

Phase

Large-scale testing

Sponsor

Aldeyra Therapeutics, Inc.

Enrollment target

~20 participants

Started

February 2026

Primary completion

December 2026

Age range

21 Years and older

Last updated February 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.